Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00358046. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Dose-Ranging, Single-Blind, Efficacy and Tolerability Study of ILY101 in Patients With Chronic Kidney Disease With Hyperphosphatemia on Hemodialysis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, dose-ranging, efficacy and tolerability study in chronic kidney disease patients with hyperphosphatemia on hemodialysis. Patient participation in the study is approximately 10 weeks in duration.
Study identification
- NCT ID
- NCT00358046
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2006 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Feb 7, 2007
Started 2006
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Study Site | Mobile | Alabama | — | — |
| Clinical Study Site | Mountain View | California | — | — |
| Clinical Study Site | Riverside | California | — | — |
| Clinical Study Site | San Diego | California | — | — |
| Clinical Study Site | Thornton | Colorado | — | — |
| Clinical Study Site | Ocala | Florida | — | — |
| Clinical Study Site | Palm Beach Gardens | Florida | — | — |
| Clinical Study Site | Pembroke Pines | Florida | — | — |
| Clinical Study Site | Des Moines | Iowa | — | — |
| Clinical Study Site | Baton Rouge | Louisiana | — | — |
| Clinical Study Site | Rochester | New York | — | — |
| Clinical Study Site | Allentown | Pennsylvania | — | — |
| Clinical Study Site | Houston | Texas | — | — |
| Clinical Study Site | San Antonio | Texas | — | — |
| Clinical Study Site | Provo | Utah | — | — |
| Clinical Study Site | Salt Lake City | Utah | — | — |
| Clinical Study Site | Norfolk | Virginia | — | — |
| Clinical Study Site | Appleton | Wisconsin | 54911 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00358046, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 7, 2007 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.